Skip to main content
GS

Gulf Sterilization, Inc.

The startup specializes in contract sterilization services for medical devices using CD gas technology, which ensures effective sterilization with no detectable emissions or residuals. This environmentally conscious approach addresses the need for reliable and sustainable sterilization solutions in the medical device industry.

Mobile, United StatesFounded 20222100+ followers
Updated 3 months ago

Funding

$880K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Medical device manufacturers face the challenge of ensuring effective sterilization while minimizing environmental impact and residual chemicals on devices. Traditional sterilization methods may involve harmful emissions or leave undesirable residues.

Solution

Gulf Sterilization provides contract sterilization services for medical devices, utilizing chlorine dioxide (CD) gas technology. Their process ensures effective sterilization with no detectable emissions or harmful residuals, offering an environmentally conscious and safe alternative to traditional methods. The CD gas sterilization cycle occurs within a chamber, including preconditioning with humidification, conditioning, generation and delivery of chlorine dioxide gas, exposure, and aeration. Gulf Sterilization assists clients in developing appropriate sterilization validation protocols and offers services ranging from single-box to multiple-pallet sterilization.

Target Audience

The primary customers are medical device manufacturers seeking contract sterilization services that are both effective and environmentally responsible.

Features

  • Chlorine dioxide (CD) gas sterilization, a registered sterilant with the US EPA
  • Sterilization process that leaves no harmful residuals
  • Demonstrated reduction of endotoxins
  • Compatibility with electronics
  • Non-carcinogenic sterilant
  • Development of sterilization validation protocols
  • Large-scale contract sterilization capabilities, from single boxes to multiple pallets
  • Decontamination services for non-FDA validated equipment
  • ISO 13485:2016 certification, aligning with ISO 14937 and FDA requirements
This profile is AI-generated and may contain inaccuracies.